Morteza Mahmoud, PhD is Assistant Professor, Precision Health Program at Michigan State University and a member of the Connors Center for Women’s Health & Gender Biology at Brigham Women’s Hospital, Harvard Medical School. Previous postings include: Assistant Professor at Harvard Medical School; Visiting Professor Stanford University School of Medicine. Founder of the “NanoBiotechnology” group. Author of >250 papers (>27,000 citations) with >12 issued/pending US and International patents. He is among 2018 and 2020 highly cited researchers, as reported by Clarivate Analytics. His specific research interest is in nanomedicine and regenerative medicine for the development of new nano-based platforms for prevention/treatment of life-threatening conditions such as cardiomyopathy, cancer, neurodegenerative diseases and chronic wounds.

Monica legal specialty is Corporate, Private Equity and M&A deals. She has had roles as a Legal Director or Consultant at Noor Solar Technology, Clyde & Co, and T&S Associates.

Keith is i2r medical’s Managing Director and is leading the company’s effort to develop a wound healing devices specifically for the treatment of diabetic foot and leg wounds at an early stage to prevent infection and subsequent complications including amputations. He has over 25 years experience in developing medical devices and working closely with clinicians and researchers all over the world as well as having professional qualifications in product design and Intellectual Property management.

Stephan has more 27 years in the MedTech industry with a strong focus and experience in wound care. He has held numerous general management positions at listed and private equity back companies including at Sastomed, Molnlycke, Gambro, and Johnson & Johnson.

Chad has more than 25 years of experience, primarily in the areas of biotech regulatory, clinical, compliance, intellectual property, business development, litigation, and general corporate legal affairs. Prior to joining Tetra he served as the Chief Clinical & Legal Officer for Cohera Medical, where he led the clinical, regulatory and legal aspects of commercialization of the first ever approved 100% synthetic absorbable surgical adhesive. He brings intellectual property experience from the law firm of Howard and Howard, and experience from Zassi Medical and the Surgical Group of the Stryker Corporation where he held regulatory and legal related positions.

Chad holds a JD from Michigan State University and a bachelor’s degree in biomedical engineering from Tulane University. He also has conducted MBA studies at Boston University. He is admitted to practice before the U.S. Patent and Trademark Office and is a member of the Michigan Bar.

Andrew has more than 30 years’ experience in bringing wound care products of many and diverse technologies to market across a range of European countries. Experienced in start-ups and product development as well as in bringing mature products to new markets. Previous roles and experience include Regional Vice-President for ConvaTec for Scandinavia and Central & Eastern Europe; Managing Director of Insense Ltd (biotech and woundcare), non- executive director on medical device start-ups, fund-raising for new businesses. Andrew is a Member of the European Wound Management Association (EWMA)

Shahriar is a research scientist at Michigan State University who also has a diverse history of working within the medical device industry. His experience includes development of resorbable medical devices, verification, and validation of resorbable devices for CE and FDA industry. Skilled in resorbable polymer synthesis, characterization, hydrogels, GMP production, design control, auditing and Quality Assurance processes. Shahriar is also an experienced Notified Body assessor for ISO-9001, ISO-13485, MDD and MDSAP and a Certified BSI Auditor. He is responsible for PGWC’s quality control process and regulatory efforts associated wtih product development.

Samad has over 10 years’ experience in financial services working in the fixed income sales & trading divisions of top tier investment banks (Morgan Stanley, Goldman Sachs, and Barclays) specializing in structured investment and hedging solutions for financial institutions. Samad holds a Master’s degree in International Management from Bocconi University in Milan and a BSc in Business Administration from the University of Turin.

Samad’s primary role at PGWC is to support fundraising and investor relations as well as advising on budgeting and business planning.

Mohammad Raoufi, PhD, is a Visiting Professor at University of Siegen, Germany, an Assistant Professor at Tehran University and a Researcher at Max Planck Institute. He has 9 years of experience as R&D scientist and project leader, teaching in nanotechnology, polymer physics, physical chemistry and biophysics. Prof. Rauofi’s research has focused on tissue engineering and protein interactions with over 20 scientific papers in international journals and  multiple patents pending.

Prof. Raoufi is a co-inventor of PGWC’s proprietary nanofibre extrusion process and is responsible for driving process development involving materials selection, characterization, biological evaluation and feasibility testing.

Mart has more than 25 years’ experience in medical device start-ups, with roles including Managing Director, VP Europe, VP International. Strategic planning and international business development, with extensive experience in introduction of new technologies to new markets, working with early-stage medical device companies.

Mart is responsible for PGWC’s overall business structure and communications, coordination of resources, identification of strategic objectives and pathways and the implementation of company plans.

Jafar has over 30 years’ experience within the industrial sector, including automotive and renewable energies in which he has 20 years’ experience as founder and managing director. Role and responsibilities at PGWC: Jafar coordinates the process engineering aspects of scaling the technology and advises on all budget related matters, providing consultation on project management to ensure that overall project costs are effectively managed. He is also responsible for corporate governance and participates in fundraising and finance efforts.